首页> 外文期刊>Indian heart journal >Fractional Flow Reserve: Intracoronary versus intravenous adenosine induced maximal coronary hyperemia
【24h】

Fractional Flow Reserve: Intracoronary versus intravenous adenosine induced maximal coronary hyperemia

机译:分数血流储备:冠脉内与静脉内腺苷引起的最大冠状动脉充血

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Fractional Flow Reserve (FFR), a measure of coronary stenosis severity is based on the achievement of maximal hyperemia of coronary microcirculation. The most widely used pharmacological agent is adenosine which is administered either by intra coronary or intra venous routes. IV route is time consuming, has more side effects and expensive. This study is undertaken to compare the two routes of administration.Methods: FFR was assessed in 50 patients with 56 intermediate focal lesions using both IV and intracoronary (IC) adenosine. FFR was calculated as the ratio of the distal coronary pressure to the aortic pressure at maximal hyperemia.Results: A total of 25 left anterior descending, 8 right, 21 circumflex, and 2 left main coronary arteries were evaluated. The mean percent stenosis was 63.91 +- 13.13 SD and, the mean FFR was 0.831 +- 0.0738 SD for IV and 0.832 +- 0.0707 SD for IC adenosine. There was a strong and linear correlation between 2 sets of observations with IV dose and IC adenosine dose (R = 0.964, y = 0.065 + 0.923x; p < 0.001) (y = IV dose, x = IC dose). The agreement between the two sets of measurements was also high, with a mean difference of: 0.001 +- 0.0197. The changes in heart rate and blood pressure were significantly higher in IV adenosine group. Different incremental doses were well tolerated, with fewer systemic adverse events with IC adenosine. Transient AV blocks were observed with both IV and IC adenosine.Conclusions: This study suggests that IC adenosine is equivalent to IV infusion for the determination of FFR. The administration of IC adenosine is easy to use, cost effective, safe and associated with fewer systemic events.
机译:背景:分数血流储备(FFR),一种衡量冠状动脉狭窄严重程度的方法,是基于冠状动脉微循环最大充血的实现。最广泛使用的药物是腺苷,它可以通过冠状动脉内或静脉内途径给药。静脉内途径是费时的,具有更多的副作用并且昂贵。这项研究旨在比较两种给药途径。方法:使用静脉内和冠状动脉内(IC)腺苷对50例具有56个中度局灶性病变的患者进行FFR评估。 FFR计算为最大充血时远端冠状动脉压力与主动脉压的比值。结果:总共评估了左前降支25个,右向8个,回旋支21个和左主干动脉2个。狭窄的平均百分比为63.91±13.13SD,IV的平均FFR为0.831±0.0738SD,IC腺苷为0.832±0.0707SD。两组IV剂量和IC腺苷剂量的观察值之间存在强线性相关性(R = 0.964,y = 0.065 + 0.923x; p <0.001)(y = IV剂量,x = IC剂量)。两组测量值之间的一致性也很高,平均差为:0.001±-0.0197。静脉内腺苷组的心率和血压变化明显更高。 IC腺苷对不同的增量剂量耐受良好,全身不良事件较少。结论:本研究表明,IC腺苷等效于IV输注,以测定FFR。 IC腺苷的管理易于使用,具有成本效益,安全且与较少的全身事件相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号